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Abstract
Background/Aims. Chondroitin sulfates are
glycosaminoglycans bound to core proteins of
proteoglycans in the extracellular matrix and
perineuronal nets surrounding many types of
neurones. Chondroitin 4- and chondroitin 6- sulfate
can bind calcium ions with different affinities,
depending on their sulfation position. Extracellular
calcium plays a key role in determining the
transmembrane potential sensed by voltage-operated
ion channels (VOCs) by means of the “surface
screening effect” theory (Gouy-Chapman-Stern
theory). We wanted to test whether chondroitin
sulfates at physiological concentration can effectively
modulate the gating properties of VOCs. Methods.
We recorded in patch-clamp experiments the shift of
h and voltage-dependent calcium currents activation
curves of Xenopus laevis photoreceptors perfused
with chondroitin sulfate solutions in physiological
extracellular calcium concentration. Results. We found
that chondroitin 4- and 6- sulfate, with different
capabilities, can shift the activation curve of h and
voltage-dependent calcium channels, compatibly with
the surface screening effect theory. Conclusion.
We conclude that chondroitin sulfates can alter VOCs
gating by modulating the calcium concentration in the
extracellular microenvironment. This phenomenon
may explain why alterations in the chondroitin sulfation
and abundance in the extracellular matrix are found
along with altered neuronal function in pathological
conditions.
Introduction
Cells are surrounded by a complex extra-cellular
matrix (ECM) and receive nutrients and signals from it.
Among the different types of molecules that compose
ECM, glycosaminoglycans (GAGs) have different chemi-
cal, physical, mechanical and biological properties [1, 2].
Chondroitin sulfates (CSs) are a heterogenic group of
GAGs bound to a core protein of proteoglycans (PG).
CSs consist of repeating disaccharide units formed by
D-glucuronic acid β (1-3)D-N-acetyl galactosamine β (1-
4). They can be sulfated at positions 4 (CS4) or 6 (CS6)
of N-acetyl galactosamine, or in position 2 of the uronic
acid. Sulfation is critical to modulate the PGs interaction
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with other molecules, like growth factors and
chemokines [2].
Cations can be chelated by negatively charged
sulfate and carboxylic residues and GAG sulfation pat-
tern plays a fundamental role in determining whether the
polysaccharide chains have the capability to bind calcium
ions. In this respect, it is known that CS4 has a higher
calcium chelating capability than CS6 and hyaluronan,
the only unsulfated GAG [3]. While calcium binding to
other GAGs like heparin has a critical role in blood co-
agulation, the physiological functions of the metal chelating
capabilities of other GAGs are not clear yet.
In response to various physiopathological stimuli,
such as inflammation, a remodelling of ECM occurs, de-
termining a change in GAGs composition and sulfation
pattern [4, 5]. This remodelling is due to the action of
different enzymes such proteases, glycosidases and
sulfatases that are known to be activated in several patho-
logical conditions. These enzymes can dramatically
modify the chelating capability of GAGs, altering the free
calcium concentration at the outer cell membrane sur-
face.
Extracellular free calcium is essential in cellular proc-
esses such as neurotransmitter release and muscle con-
traction. Moreover, the extracellular free calcium con-
centration also modulates the transmembrane potential
by a phenomenon known as “surface potential theory”
(Gouy-Chapman-Stern theory, [6]). In fact, membrane
phospholipids carry a net negative charge (due to their
polar heads), that can be subject to varying degrees of
“screening” by means of positively charged divalent cati-
ons. This phenomenon can lead to a different transmem-
brane voltage drop with respect to the average voltage
difference across the two compartments. Given that the
voltage sensor moiety of ion channels is embedded in the
thickness of the cell membrane, it responds to the actual
voltage drop across the membrane. Among the ions that
can play a role, one of the most effective in screening is
calcium [7]. The variation of extracellular free calcium
leads to a different screening effect on the outer side of
the membrane and this in turn leads to a change in the
voltage drop across the membrane, that voltage depend-
ent channels sense and respond to [8-10]
Vertebrate photoreceptors express a hyperpolarisa-
tion-activated current (Ih) responsible of the so called
“sag” in the typical membrane potential response to
flashes of light [11]. This current activates at membrane
potentials below -60 mV, and has been found to be very
sensitive to the aforementioned screening effect [12].
This makes it a good candidate to investigate the effect
of different CSs at physiological concentrations on the
gating properties of voltage-dependent ion channels
recorded in physiological extracellular calcium concen-
tration, which is the aim of the present work.
Material and Methods
Solutions
Since the effect observed in this work is very sensi-
tive to extracellular ion concentrations, extreme care has
been taken to assure that each solution used, especially
control vs. CS-containing solutions, had the exact same
pH, osmolality and chloride ions concentration. In fact,
since chloride ions determine the junction potential be-
tween the Ag/AgCl electrode and the solution in the bath,
unbalanced concentrations between control and test so-
lutions give rise to a different junction potential that
causes artefactual recordings.
All chemicals have been purchased from Sigma-
Aldrich, Milan, Italy, unless otherwise specified. Concen-
trations are in mM.
Standard extracellular solution: NaCl, 110; KCl, 2.5;
CaCl2, 1; MgCl2, 1.6; HEPES, 10; pH 7.6, final osmolal-
ity 242 mOsm/Kg adjusted with D-Glucose (usually less
than 15 mM).
Intracellular solution: NaCl, 4; KCl, 52.7;
K-Gluconate, 52.3; MgCl2, 2.5; EGTA free acid 5; HEPES
10; pH 7.2; final osmolality 238 mOsm/Kg adjusted with
D-Glucose (usually less than 10 mM).
CS solutions: chondroitin 4 sulfate (CS4) and chon-
droitin 6 sulfate (CS6) were purchased from Seikagaku
(Tokyo, Japan) as di-sodium salts and were purified from
whale and shark cartilage, respectively. The molecular
mass of the CS4 and CS6 is about 20 and 43 kDa, re-
spectively (Seikagaku, personal communication).We used
a concentration of 15 mg/ml of CSs (see discussion),
which corresponds to a concentration of 30 mM of CSs
disaccharide. Given that the putative calcium binding site
is composed by the disaccharide unit [13], this approach
also helps to determine the concentration of the available
calcium binding sites in the solution.
CS4 external solution: CS4-2Na, 30; NaCl, 50; KCl,
2.5; CaCl2, 1; MgCl2, 1.6; HEPES 10; pH 7.6; osmolality
242 mOsm/Kg adjusted with D-Glucose (usually less than
15 mM).
CS6 external solution: CS6-2Na, 30; NaCl, 50; KCl,
2.5; CaCl2, 1; MgCl2, 1.6; HEPES 10; pH 7.6; osmolality
242 mOsm/Kg adjusted  with D-Glucose (usually less
than 15 mM).
Vigetti/Andrini/Clerici/Negrini/Passi/MoriondoCell Physiol Biochem 2008;22:137-146
139
Extracellular control solution: Na-Gluconate, 60;
NaCl, 50; KCl, 2.5; CaCl2, 1; MgCl2, 1.6; HEPES, 10;
pH 7.6; osmolality 242 mOsm/Kg adjusted with D-Glu-
cose (usually less than 15 mM).
For calcium current recording: extracellular: Tetra
Ethyl Ammonium Chloride (TEA), 30; CaCl2, 1; KCl, 2.5;
MgCl2, 1.6; HEPES, 10; CS4-2Na, 30; NaCl, 50; pH 7.6
with NaOH, osmolality 242 mOsm/Kg adjusted  with
D-Glucose (usually less than 7 mM).
Intracellular: N-methyl-D-glucamine, 95; TEA, 25;
MgCl2 2.5; EGTA, 5; HEPES, 10; NaCl, 4; pH 7.2;
osmolality 238 mOsm/Kg adjusted with D-Glucose
(usually less than 5 mM).
CSs quantifications
To assess the purity of CSs used in this work, we
used polyacrylamide gel electrophoresis of fluorophore-
labeled saccharides (PAGEFS) technique [14]. Briefly,
we prepared 1 mg/ml solution of CS4 and CS6, digested
them with chondroitinase ABC (Sigma) and hyaluronidase
SD (Seikagaku), derivatized the obtained unsaturated
disaccharides with 2-aminoacridone (AMAC, Fluka) and
separated them on polyacrylamide gels. To accurately
measure the CS4 and CS6 disaccharides composition of
Xenopus laevis retina, we dissected two retinas, removed
proteins by proteinase K (Finnzymes) treatment and
obtained the AMAC-labeled disaccharides as described
above. Their quantification was performed by HPLC
[14]. The water content of the retinas was obtained as
[(Ww-Wd)/Ww]*100, where Ww is wet weight and Wd is
dry weight.
Animal handling
Xenopus laevis have been housed in automated
racks (XenoPlus, Tecniplast S.p.A., Buguggiate (VA)
Italy) according to standard water parameters in 14/10
light/dark cycle. Animals were sacrificed according to
the guidelines of the University of Insubria Ethical
Committee. Eyeballs were removed and immediately
processed for photoreceptor harvesting.
Photoreceptor dissociation procedure
In order to reduce the number of animals used in
this work, one eyeball was kept in standard extracellular
solution plus 2% foetal bovine serum (FBS) in an ice bath
for the next day, while the other was immediately used
for the experiment of the day. No differences in overall
response have been observed between photoreceptors
belonging to either eye. The eye was open by fine
scissors along the ora serrata under stereomicroscopic
view in a petri dish containing ice-cold extracellular solu-
tion plus 2% FBS. After removal of the cornea and lens,
the retina was gently peeled off and divided into three
small pieces. The three pieces were mechanically disso-
ciated in a 0.5 ml volume of ice-cold extracellular solu-
tion plus 2% FBS in an eppendorf tube by means of gen-
tle pipetting with a P1000 pipette. Fifty microliters of the
photoreceptor suspension were plated onto 35mm petri
dishes (Nunclon™ Δsurface, Nunc GmbH, Wiesbaden,
Germany) on an ice bed and let settle for at least 30
minutes before adding 2 ml of extracellular control solu-
tion to the petri dish and begin the electrophysiological
experiments.
Electrophysiological recording
The patch-clamp setup was composed of an inverted
microscope (IM, Carl Zeiss, Heidelberg, Germany)
equipped with an electromechanical manipulator
(PatchMan, Eppendorf, Milan, Italy) for electrode fine/
coarse movement, a mechanical manipulator (Narishige,
Tokyo, Japan) to manually drive the fast multi-line solu-
tion changing head, an Axopatch 200B patch-clamp am-
plifier, a Digidata 1200B A/D board (Axon Instruments,
now Molecular Devices, Sunnyvale, CA, USA), and a
PC running Pclamp 6 software (Molecular Devices,
Sunnyvale, CA, USA ) for cell stimulation and data ac-
quisition and analysis. Electrical zeroing of the pipette
offset was performed in extracellular control solution, and
a single cell was used in each petri dish to avoid contami-
nation from previous experiments. Solutions were quickly
changed onto the recorded cell by means of a manually
operated multi-line perfusion head aligned with the cell.
Solutions were gravity fed to the cells with a flow rate of
0.5 ml/min. Signals were filtered by the integrated low
pass Bessel filter of the Axopatch 200B at 2 KHz and
acquired at 10 KHz, stored on the PC and analysed off-
line. Patch pipettes were pulled with a PP83 vertical puller
(Narishige) from borosilicate glass capillaries (PG120T-
7.5, Harvard Apparatus, Holliston, Massachusetts, USA).
When filled with intracellular solution, their resistance in
the bath was between 5.5- 6 MΩ. Access resistance was
always < 10 MΩ and input resistance typically > 1.5 GΩ
in all the cells considered for this work. Series resistance
was compensated at 70% to avoid oscillation of the com-
pensating circuit upon cell perfusion. Electrophysiological
recordings have been obtained from light-adapted
Xenopus laevis principal rods in the whole-cell
configuration of the patch-clamp technique. Stimulation
protocols are shown in the figures or described in
the text where appropriate.
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Data fitting
Experimental data were fitted with the Boltzman
equation in the form
with Origin software (Origin Lab, Northampton, MA,
USA) where: Gmax= maximum relative conductance with
respect to control, V1/2 = half-activation potential [mV],
Vm = membrane potential [mV], k = slope factor [mV].
Atomic absorbance spectrometry
In order to obtain the chelation curve for CS4,
15 mg/ml solutions of CS4 in PBS buffer (Euroclone, with-
out calcium) were prepared, containing 0, 1, 5, 10, 50,
100, and 200 mM of CaCl2. To determine calcium bound
to CS4, free calcium ions were separated from CS4 by
gel filtration using PD10 column (GE healthcare) and
eluted with PBS following a modification of the manu-
facturer’s instruction. Briefly, the column was equilibrated
with 25 ml of PBS without calcium, 2.5 ml of CS4 solu-
tion were loaded on the top of the column and the 2.5 ml
of eluate were discarded. To elute CS4, 2.0 ml of PBS
were loaded on the top of the column and the 2.0 ml of
eluate were collected. Calcium bound to CS4 was quan-
tified by using flame (air-acetylene) atomic absorbance
spectrometry (AAS) on a Unicam Solaar M instrument
equipped with a deuterium lamp. Wavelength (422.7 nm),
band pass (0.5 nm), and all other instrumental param-
eters were set according to the usual recommendations
of the instrument manufacturer. Moreover, lanthanum
was added to the solutions to reduce interferences with
matrix, after the methods in [15].
In order to compare the binding capability of vari-
ous GAGs, 15 mg/ml solutions of CS4, CS6 and hyaluronan
in PBS with 1 mM of CaCl2 were prepared, free calcium
was separated from GAG chelated calcium by using
PD10, and calcium bound to GAGs was assayed as
described above.
Data are presented as mean ± s.e.m. Statistical
significance has been assessed with Student’s t-test at
p<0.05.
Results
Principal rods of Xenopus laevis display Ih current
when hyperpolarised from a holding membrane potential
of -60 mV (Fig. 1A, extracellular control solution).
We used the activation curve of h current (control condi-
tion, V1/2= -95.15 ± 0.19 mV, k= 6.72 ± 1.08 mV
n=5 Fig.1B) as the very sensitive probe to investigate the
possible effect of CSs on membrane potential (and thus
on voltage-gated ion channels). Before proceeding with
electrophysiological experiments, the same CS solutions
used with rods have been assessed for purity and cal-
cium binding properties. As the commercial CS4 and CS6
were purified from biological sources, we assessed their
purity by using PAGEFS analysis and found that the two
GAG solutions contained essentially the corresponding
disaccharide without contamination from hyaluronan or
unsulfated CS (Fig. 2A) indicating that each CS solution
used had a very high degree of purity. The calcium
binding capability of CS4 is shown in Figure 2B and, at
calcium concentrations higher than 50 mM, saturation
occurred. Since sulfation position modifies the chelating
Fig. 1. (A). Current traces
of Ih elicited in control
external solution by means
of the stimulation protocol
showed in the upper panel.
(B). Conductance-Voltage
relationship of Ih obtained at
steady-state by averaging
the last 20 ms of each trace
recorded at different
membrane potentials like the
ones reported in A, and
superimposed Boltzman
fitting (parameters given in
the text).
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Fig. 2. (A). PAGEFS analysis of CS4 and CS6 purity. One mg/
ml solutions of CS4 and CS6 were treated with chondroitinase
ABC and hyaluronidase SD to obtain GAG unsaturated
disaccharides, and labelled with AMAC. The fluorotagged
disacchararides were separated by PAGEFS and bands were
visualized under UV light. Standard lane contains pure unsatu-
rated disaccharides of CS4 (ΔCS-4S), CS6 (ΔCS-6S), hyaluronan
(ΔHA), and chondroitin 0 sulfate (ΔCS-0S). (B) Calcium bind-
ing capability of CS4 at increasing calcium concentrations. Fif-
teen mg/ml of CS4 were incubated with increasing calcium con-
centrations, free calcium was separated to calcium bound to
CS4 by gel filtration using PD10 column and bound calcium
quantified by AAS. (C). Calcium binding capabilities of differ-
ent GAGs. Fifteen mg/ml of solutions containing CS4, CS6,
hyaluronan (HA), or no GAG (CNT) were incubated with 1 mM
calcium and the calcium bound to each GAG was quantified as
described in B. nd not detectable.
capabilities of CSs [16], we incubated the same amount
of CS4 and CS6 with 1 mM calcium (Fig. 2C) and found
that CS4 was able to bind significantly more calcium than
CS6 (0.092 ± 0.001 mM for CS4 vs. 0.066 ±
4.03⋅10-5 mM for CS6, p<0.01, n=3). The efficiency of
the procedure to separate free calcium ions from those
bound to CSs was verified by loading on the column a
calcium solution without CSs and finding that, in the
2.0 ml of eluate, no calcium was detectable (Fig. 2C).
Moreover, we loaded onto the PD10 column the calcium
solution plus hyaluronan, another GAG known to have
poor calcium chelating capabilities as it lacks sulfations
[3], and found limited calcium associated with such GAG
(Fig. 2C).
In CS4 solution, Ih activation curve significantly
shifted to the left, and was fitted with a Boltzman equa-
tion with V1/2 = -105.90 ± 0.65 mV (ΔV1/2 = -10.75 ±
1.24 mV, p<0.01 with respect to control, n=5), and
k = 6.85 ± 0.68 mV (Fig. 3A, not significantly different
from control).
When cells were superfused with CS6 containing
solution, the Ih activation curve changed again with re-
spect to control, but in a different way compared to CS4
perfusion (Fig 3B-C). In fact V1/2 was significantly dif-
ferent from control (-102.17 ± 1.08 mV, p<0.05, n = 5),
and not different from the V1/2  obtained in CS4, but k did
significantly change with respect to control (9.08 ±
1.12 mV, p<0.05, n=5). The superposition of the three
fitted Boltzman equations obtained in the three conditions
(Fig. 3D, control, solid line; CS4 perfusion, dashed line;
CS6 perfusion, dotted line) shows a greater difference
between CS4 and CS6 for voltage potentials near the
activation threshold of Ih, whereas for lower membrane
potentials close to the maximum activation of Ih the two
plots are virtually identical. Moreover, while CS4 activa-
tion-shift effect encompasses all the activation range of
h channels, CS6 curve is different from control curve
only for midrange membrane potential values, as expected
from the different slope factor k.
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Since CS4 is known to be present in the plexiform
layers of vertebrate retina [17, 18] we wanted to test the
possibility that CS4 could alter the voltage-dependent
calcium current present at the level of rod photoreceptors
presynaptic terminals, which reside in the outer plexiform
layer in intact retinas. The current-voltage (I-V) plots of
actual calcium currents obtained both with voltage ramps
and at steady state in 1mM extracellular calcium showed
a leftward shift with respect to control both in steady-
state I-V plot (Fig. 4A, wash trace omitted for clarity)
and instantaneous I-V plots (Fig. 4B), with a shift of
 -10 mV of the peak current at steady-state. The time
course of the calcium current (Fig. 4C) was not affected
by the application of CS4. Effects of CS4 on calcium
current were not readily reversed upon returning in con-
trol solution, as illustrated by the incomplete recovery of
the current visible in figure 4C, wash trace. We next
wanted to assess the effect on the voltage dependent
calcium current of increasing concentrations of CS4.
Figure 4D shows the averaged fitted Boltzman equations
obtained from the activation curve of the voltage depend-
ent calcium current recorded by voltage ramps as in
figure 4B at different CS4 concentrations. Each Boltzman
Fig. 3. G-V relationships and their
respective superimposed Boltzman
fits (parameters in the text): (A) in
control (filled squares) or in the
presence of CS4 (open circles). (B). in
control (filled squares) or in the
presence of CS6 (open triangles). (C).
in CS4 perfused cells (open circles)
and CS6 perfused cells (open
triangles). (D). Boltzman fits in control
(solid line), CS4 perfusion (dashed
line) and CS6 perfusion (dotted line).
curve is the average of the single curves fitted on each
of the 5 cells tested for each chondroitin solution. Table 1
summarises the values of V1/2 and k in control (without
CS4) and with increasing concentrations of CS4.
 It is worth to note that, while increasing the concentra-
tion of CS4 from 30 mM to 100 mM induces an addi-
tional leftward shift of -9.54 mV in V1/2 , decreasing CS4
concentration from 30 mM to 10 mM has a marginal
effect on V1/2. In fact, the effect on V1/2 is almost statis-
tically significant if compared to the control value also
for a CS4 concentration of 10 mM. The slope factor k is
never significantly different from control value or between
different CS4 concentrations.
To further confirm that CS4 concentrations used in
the electrophysiological experiments reflected the actual
concentration of CS4 in Xenopus laevis retinas, we quan-
tified the CSs by HPLC analysis of retinal extracted CSs.
We found a retinal water content of 93%, in good
agreement with the 84% found in rat retinas [19], also
considering that Xenopus are fresh-water animals. CS4
and CS6 content were 0.005 mg/mg dry tissue weight
and 0.0057 mg/mg dry tissue weight, respectively.
The estimation of the extracellular volume of mamma-
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Fig. 4. (A). Steady-state current-voltage
(I-V) plots of actual calcium current in
isolated rods recorded in control
condition (filled squares) and CS4
perfusion (open circles). Wash trace
omitted for clarity. Data points are the
average of the last 10 ms of the current
traces elicited in response to a variable
step stimulation protocol from -80 mV to
+ 80 mV in 10-mV increments of 100 msec
of duration (as in C) (B). Istantaneous
calcium current I-V plot of rods obtained
with voltage ramps from -80 to +80 mV of
300 msec. duration. (C). Calcium current
traces obtained at the specified
membrane voltages from a holding
potential of -60 mV. Asterisk, CS4
perfusion, wash trace in gray. (D) Dose
effect of increasing CS4 concentrations
on the activation curve of the voltage
dependent calcium current of Xenopus
rods. Each trace is the average Boltzman
fit of single fits for each of the five cells
used for each concentration. Grey trace
corresponds to CS4 30 mM, which is the
concentration used in the other
experiments of panels A-C. Fit parameters
are listed in table 1.
Table 1. Student’s t-test val-
ues: * p<0.05 with respect to
control; ** p<0.05 with re-
spect to control, CS4 10 mM
and CS4 30 mM; ° p=0.057 with
respect to control. n=5 for all
concentrations.
lian retina has been elegantly and exhaustively performed
in another work and found to be 1.80 ml/gr dry tissue
weight [20]. Taken together, these data give average CS4
and CS6 concentrations in the whole retina of 2.78 and
3.16 mg/ml extracellular fluid, respectively, which are com-
parable to the concentrations we used in
electrophysiological experiments (see Discussion for
details).
Discussion
The calcium chelating properties of CSs have been
studied in non physiological calcium solutions [3, 13].
Our present data show that even at physiological extra-
cellular calcium concentration (1 mM), CS4 and CS6
display different calcium binding potencies due to their
different sulfation position.
In ECM, CSs concentration ranges from 0 to
3 mg/g dry tissue weight [21]. However, since most of
the tissue volume (especially in the central nervous
system and highly packed tissues) is occupied by cells,
the actual CSs concentration can be higher (up to ten
times the measured one), as previously reported in the
epidermis [22]. Hence, the CSs concentration used in
the present work (15 mg/ml) may be a good estimate of
the actual tissue concentration. In the retina, the
chondroitin concentration obtained by us (see Results)
can be regarded as a lower estimate of the actual
concentration at the photoreceptor synapse, were the
voltage-dependent calcium current is located. In fact, it
is known that chondroitins accumulate in the so called
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“Interphotoreceptor Matrix” (IPM) which surrounds rods
and cones [18, 23, 24]. This causes a local increase of
actual CSs quantity around photoreceptors compared to
the average one we measured from the whole retina ex-
tracts, thus resulting in an uneven distribution of
chondroitins in the whole retina. This in turn leads to an
increase of the actual concentration at the photoreceptor
synapse.
The leftward shift of the activation curve of Ih when
cells were perfused with CS4 solution is compatible with
what can be expected from the screening effect theory:
the decrease of calcium concentration due to CS4 bind-
ing un-screens negative charges on the outer membrane
surface, bringing the outer membrane potential closer to
the value of the inner one, a phenomenon sensed as a
“depolarisation” by the voltage sensors of voltage-depend-
ent ion channels like the h channels. Thus, to obtain the
same degree of activation with respect to control, the
membrane potential had to be set to a more negative
value.
Moreover, CS6 was able to shift the V1/2 of h cur-
rent activation to more negative potentials, but also modi-
fied the slope factor. This latter phenomenon has been
seen in rod h current by increasing the extracellular pH
[12]. However, this does not seem to be the case in the
present work, since extracellular pH has always been
carefully set to 7.6. However, it cannot be ruled out the
possibility that the overall effect of CS6 on Ih could be
the sum of the surface screening effect onV1/2 and the
activation of an intracellular pathway via a CS6 specific
receptor which might alter the voltage sensitivity of the h
channel. Specific CSs receptors are not known, but there
is emerging evidence from the literature that CSs (the
2,4 di-sulfate form, at least) can act as co-factors, bind-
ing growth factors and activating one of the protein tyro-
sine phosphatase receptor PTP family [25]. HARE/
Stabilin-1 is a hyaluronic acid scavenger receptor for
endocitosis which is able to bind CS4 and CS6, too [26],
so it cannot be completely excluded that the CS6-medi-
ated effect on the slope factor might be due to the acti-
vation of a HARE- or PTP-like receptor.
In the functional assay on the photoreceptor cal-
cium current, the I-V plots (Fig. 4) show the expected
leftward-shift of the curve in CS4 challenged cells with
respect to control. In principle one could also expect a
diminution of the current peak, due to the decreased avail-
ability of free calcium at the outward channel pore.
In our study this phenomenon has been observed in
steady-state recordings only: in these experiments,
before being stimulated with membrane test voltages in
the range of the peak of calcium current (about -10 mV),
cells have been perfused with CS4 for a longer period
than cells stimulated with the ramp protocol. Hence, it
could be inferred that the un-screening effect can be
reached quickly, whereas the peak current reduction may
need a more pronounced decrease in extracellular free
calcium concentration attainable (at least in our condi-
tions) by CS4 over a longer period of time.
The reduction in peak current observed in CS4
perfused cells (fig. 4C) is a real CS4-induced effect, not
due to a “run-down” of calcium current itself: indeed, the
current level in the wash (grey) trace obtained at -10mV
is larger than the one obtained during CS4 perfusion.
The lack of complete recovery could be ascribed to the
fact that CSs tend to stick to the membrane, so that it is
not possible to completely wash them away.
The dose effect of CS4 on the voltage activated
calcium current of photoreceptors (Fig. 4D) shows that
an increase of chondroitin sulfate in the extracellular ma-
trix can proportionally induce a relevant leftward shift in
the activation curve of voltage dependent ion channels,
as expected from the Gouy-Chapman-Stern theory and
the chelating properties of CS4. The almost statistically
significant shift of V1/2 obtained in CS4 10 mM solution
(see Table 1 for values and statistical significance) could
also indicate that even little amounts of chondroitin sulfate
in the extracellular matrix might exert a significant effect
on the gating properties of voltage dependent ion chan-
nels. Indeed, 10 mM chondroitin sulfate concentration
equals to 5 mg/ml, a concentration very close to the one
we measured as a lower estimate for the Xenopus retina
and discussed above.
The impact of a leftward shift in the I-V curve of
calcium current on the photoreceptor physiology is an
augment of synaptic release of glutamate in the dark,
which depends on the paradoxical increase of calcium
entry through voltage-dependent calcium channels [27].
Since the normal dark resting potential of photoreceptors
is set at about -40 mV, in the presence of CS4, calcium
current is higher than control at -40 mV (Fig. 4A).
It is known that proteoglycans are present in the
interphotoreceptor matrix  surrounding rods and cones
[18], and that horizontal cells express a specific type also
at the level of ribbon synapses [28]. While there is
general consensus that their presence in the IPM medi-
ates significant interactions between photoreceptors and
the retinal pigment epithelium, very little is known about
their role in the synaptic process between photoreceptors
and higher order cells. However, nyctalopin, a membrane-
bound chondroitin sulphate proteoglygan, seems to be
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involved in photoreceptor synapse proper functioning as
well as in X-linked stationary night blindness [29-33].
It might therefore be possible that chondroitin composi-
tion of the photoreceptor ribbon synapse matrix could
influence its function by way of the surface screening
effect.
Neurite outgrowth is known to be affected by the
chondroitin/hyaluronic acid composition of the  ECM  [34,
35], but at present there are supporting evidences that
CSs may play a role by activating intracellular pathways
rather than acting via a pure Gouy-Chapman-Stern
mechanism [4, 36]. Given that the deposition of
chondroitins in perineuronal nets seems to be activity-
dependent [37], the results of the present work seem
more consistent with a modulatory action of CSs on
neural cells during normal function rather than during
sprouting following injury or development.
However, a recent work on lamprey neurones [38]
indicates that an increase in calcium current through
L-type calcium channels results in an inhibition of neurite
outgrowth. The same increase in calcium current is seen
in a CS4 enriched environment, as our data suggest
(Figure 4), and thus it is not possible to completely rule
out the possibility that CSs could also act on axonal
regeneration via a surface screening effect.
In conclusion, the present data indicate that CSs can
bind calcium with different affinities, and this in turn can
affect the transmembrane potential sensed by voltage
gated ion channels. The effect of CS4 (and, to a lesser
extent, of CS6) on neurones and other excitable cells
would be a membrane depolarisation that could favour
reaching of the threshold for spike generation. In fact
neurones are surrounded by the so-called “perineuronal
nets”, composed of different PGs whose side chains are
made mainly of CSs [39, 40]. It can be postulated that
the GAGs composition of PGs might influence the elec-
trical behaviour of excitable cells by way of the “surface
screening” effect. Such a modulating role of the ECM
GAGs with respect to the electrical behaviour of neu-
rones might possibly explain why macromolecular ECM
composition around many high-frequency spiking neurones
is different from other areas of the nervous system
[41-43], and / or why the decrease in CSs content in
Alzheimer’s disease correlates with the loss of function
of parvalbumin-positive inhibitory interneurones [44].
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